News

Success for drug researchers at the University Alliance Ruhr
Around 1,200 Germans are diagnosed with gastrointestinal stromal tumours (GIST) every year - a rare type of cancer in which the tumours develop in the walls of the digestive organs and which quickly develop resistance to common precision drugs.  more

A team of RNA scientists, chemists and cancer biologists from Florida, Dortmund and Münster have found new possibilities for targeting cancer genes’ RNA with nature-inspired compounds more

Morphological fingerprinting could help identify side effects and new bioactive compounds in drug discovery more

Max Planck scientists from Dortmund find immunoregulatory substances with newly developed test system more

As part of his Ruhr Area tour on November 22nd the President of Germany Frank-Walter Steinmeier visited COMAS (Compound Management and Screening Center) at the Max Planck Institute (MPI) of Molecular Physiology to learn more about drug research in Dortmund. more